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ABSTRACT
Objectives To determine growth outcomes at 11 
years of age in children born <27 weeks of gestation in 
England in 2006 (EPICure2) and to compare growth from 
birth to 11 years of age for births<26 weeks with those 
in England in 1995 (EPICure).
Methods 200 EPICure2 children assessed at 11 years 
alongside 143 term- born controls. Growth measures from 
birth to 11 years were compared for births<26 weeks 
between EPICure2 (n=112) and EPICure (n=176). Growth 
parameter z- scores were derived from 1990 UK standards.
Results Among EPICure2 children, mean z- scores 
for height and weight were close to the population 
standards (0.08 and 0.18 SD, respectively) but 
significantly below those of controls: difference in mean 
(Δ) z- scores for weight −0.42 SD (95% CI −0.68 to 
–0.17), for height −0.45 SD (−0.70 to –0.20) and for 
head circumference (HC) −1.05 SD (−1.35 to –0.75); 
mean body mass index (BMI) z- score in EPICure2 
children was 0.18 SD, not significantly different from 
controls (0.43 SD, p=0.065). Compared with EPICure, 
EPICure2 children born <26 weeks at 11 years had 
higher z- scores for weight (Δ 0.72 (0.47, 0.96)), height 
(Δ 0.55 (0.29, 0.81)) and BMI (Δ 0.56 (0.24, 0.87)), 
which were not fully explained by perinatal/demographic 
differences between eras. Weight catch- up was greater 
from term- age to 2.5/3 years in EPICure2 than in 
EPICure (1.25 SD vs 0.53 SD; p<0.001). Poor HC growth 
was observed in EPICure2, unchanged from EPICure.
Conclusions Since 1995, childhood growth in weight, 
height and BMI have improved for births <26 weeks of 
gestation, but there was no improvement in head growth.
INTRODUCTION
Poor growth attainment from infancy to early 
adulthood has been reported for children born 
extremely preterm (EP) in the 1990s in comparison 
with term- born peers.1–4 However, information on 
growth outcomes is lacking for EP children born 
in the 2000s. Survival for EP babies has improved 
since 1995 in England5 6 and in other countries.7–9 
Despite reports of trends towards improved neuro-
developmental outcomes during infancy and early 
childhood for EP babies born after the 1990s,10 11 
as yet there is no evidence that early improvements 
are sustained in middle childhood. There are few 
reports of physical growth over time. We previously 
compared weight and head circumference (HC) 
for births <26 weeks’ gestation in England and 
found no improvement in somatic or head growth 
from birth to the expected date of delivery (EDD) 
between babies born in 1995 and 2006.5 Less is 
known about whether later growth parameters have 
changed since 1995.
The aims of this paper were: (1) to investigate 
growth measures at 11 years of age for children 
born <27 weeks’ gestation in England in 2006 in 
comparison with term- born controls, as part of a 
longitudinal cohort study (EPICure2 study) and (2) 
to compare growth measures from birth to 11 years 
of age for children born <26 weeks of gestation 
with those of babies born in England in 1995 who 
were followed up as part of the original EPICure 
study.4 We expected to see improved growth for EP 
children in EPICure2, but it was unclear whether 
this extended to improvement in head growth, as 
we have previously reported no change in neurode-
velopmental outcomes between the two cohorts.12
METHODS
Participants
The EPICure2 study comprises all EP births<27 
weeks of gestation in England during 2006.5 A total 
of 1041 babies survived to discharge, and children 
What is already known on this topic?
 ► Survival for extremely preterm babies has 
improved since 1995 in the UK.
 ► There was no improvement in physical growth 
from birth to full- term age between babies born 
<26 weeks of gestation in 1995 (EPICure) and 
2006 (EPICure2).
 ► It is unclear whether long- term growth 
outcomes have changed.
What this study adds?
 ► Among EPICure2 children, mean z- scores for 
height and weight at 11 years were close to the 
UK 1990 population standards but significantly 
below those of controls.
 ► Despite advancing perinatal care since 1995, 
head growth has not improved for children born 
<26 weeks’ gestation in 2006.
 ► Improvements were observed in weight, height 
and body mass index during infancy and middle 
childhood for births <26 weeks of gestation in 
2006.
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were followed up at age 3 and 11 years. Ten deaths occurred 
between discharge and the 3- year assessment. Recruitment 
and assessment at 3 years have been described previously: 576 
children were assessed.6 At 11 years, invitations to participate 
in the study were sent to a sample of parents of 482 children 
comprising births in 17 clinical neonatal networks in England. 
As part of the study design, a contemporary comparison group 
was recruited. For each EP child in mainstream school, up to 
three term- born controls were recruited from classmates of the 
same age (±3 months) and sex. Where it proved impossible 
to gain access to the school or at a parent’s request, children 
were assessed at home. In these cases, a term- born child was 
identified by the parent of the EP child where possible and was 
invited to participate in the study. For children attending special 
educational needs schools (n=22), controls were not recruited. 
Assessors were not informed of the child’s birth status. Further 
information on study procedure is provided in the online supple-
mental appendix. The EPICure study comprised all births <26 
weeks of gestation in the UK and Ireland during 1995. Recruit-
ment of the cohort has been described previously;13 315 children 
survived to discharge and were invited for follow- up assessments 
at age 2.5, 6, 11 and 19 years.
Measures
In EPICure2, growth data were collected at birth and EDD 
(weight and HC), and at age 3 and 11 years (weight, height, 
HC and body mass index (BMI)). In EPICure, growth data were 
available at birth and EDD (weight and HC), and at age 2.5, 
6 and 11 years (weight, height, HC and BMI).1 3 4 For both 
cohorts, SD or ‘z’ scores for growth measures were calculated 
based on the British 1990 growth reference adjusting for sex 
and age.14 Classification for child overweight and thinness was 
defined according to international standards using age and sex 
specific BMI cut- off points.14 Birth weight z- scores were derived 
from the original EPICure cohort data which were complete 
population samples from which the study children are drawn.15 
The Index of Multiple Deprivation 2015 (IMD), the version 
closest to assessment dates, was used as a measure of socio- 
economic status at 11 years in EPICure2 and was obtained using 
postcode of parent’s residence at the time of the assessment.16 
IMD ranks were used to derive deciles based on the English 
population with Decile 1 (most deprived) to Decile 10 (least 
deprived). The IMD 2007 version was used at 11- year assess-
ment in EPICure.
Table 1 Comparison of perinatal and childhood variables between children formally evaluated at 11 years and non- responders in 2006 birth 
cohort
Variables Children assessed at 11 years (n=200) Children not assessed at 11 years (n=831) P value
Gestational age
  22 weeks % (n/N) 0.0% (0/200) 0.4% (3/831) 0.536
  23 weeks % (n/N) 7.5% (15/200) 5.8% (48/831)
  24 weeks % (n/N) 14.0% (28/200) 17.9% (149/831)
  25 weeks % (n/N) 34.5% (69/200) 32.7% (272/831)
  26 weeks % (n/N) 44.0% (88/200) 43.2% (359/831)
Birth weight (g) Mean (SD) 810.2 (147.5) (n=200) 794.5 (149.0) (n=831) 0.181
Birth weight z scores Mean (SD) −0.2 (0.8) (n=200) −0.3 (0.8) (n=828) 0.163
Male sex % (n/N) 50.0% (100/200) 48.0% (399/831) 0.614
Multiple birth % (n/N) 24.5% (49/200) 24.0% (202/841) 0.886
Ethnicity
  White % (n/N) 59.6% (118/198) 67.0% (549/819) 0.009
  Asian % (n/N) 16.2% (32/198) 8.7% (71/819)
  Black % (n/N) 18.7% (37/198) 20.5% (168/819)
  Other % (n/N) 5.6% (11/198) 3.8% (31/819)
Maternal age at delivery Mean (SD) 30.7 (6.0) (n=200) 28.7 (6.6) (n=830) <0.001
IMD at birth Mean (SD) 4.5 (2.7) (n=198) 4.3 (2.9) (n=824) 0.287
Maternal height Mean (SD) 163.0 (6.8) (n=179) 162.7 (7.0) (n=652) 0.570
Maternal weight Mean (SD) 69.1 (16.3) (n=172) 68.2 (16.5) (n=640) 0.572
Breast milk at any time % (n/N) 98.5% (197/200) 95.7% (794/830) 0.059
Breast milk at discharge % (n/N) 56.0% (112/200) 39.3% (325/828) <0.001
No previous birth ≥24 weeks % (n/N) 54.8% (109/199) 52.5% (434/827) 0.560
Worst cerebral ultrasound scan % (n/N) 18.6% (37/199) 21.6% (179/827) 0.343
Antenatal systemic steroids % (n/N) 86.0% (172/200) 87.7% (718/819) 0.525
Postnatal systemic steroids % (n/N) 16.5% (33/200) 15.0% (125/831) 0.607
Cervical suture % (n/N) 8.0% (16/199) 5.8% (48/830) 0.236
Parenteral nutrition % (n/N) 100.0% (200/200) 99.9% (830/831) 0.624
Days to parenteral nutrition Median (range) 1 (0–6) (n=198) 2 (0–14) (n=830) 0.116
Enteral feeding begun before day 7 % (n/N) 87.5% (175/200) 82.2% (682/830) 0.070
Days to enteral feeding Median (range) 3 (0–24) (n=200) 3 (0–34) (n=830) 0.006
Feeding difficulties at 3 years % (n/N) 22.2% (34/153) 16.1% (68/423) 0.088
Severe neurodevelopment disability at 3 years % (n/N) 10.5% (16/153) 14.4% (61/423) 0.217
*1031 children survived to 3 years, among which 200 children were assessed at 11 years.
IMD, Index of Multiple Deprivation.
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Analysis
Analyses were performed in STATA V.15.1. For EPICure2, 
summary data on the neonatal variables were presented for 
those formally assessed at 11 years and those not assessed. 
Linear regression was used to estimate difference in means (Δ) 
and 95% CI for growth measure z- scores between EP children 
and controls at 11 years, as well as to investigate impacts of 
gestational age in weeks and days on growth. For the compar-
ison between EPICure and EPICure2, we only included births 
<26 weeks’ gestation to women resident in England at birth. 
We compared growth measures at comparable ages between the 
two cohorts and examined the trend over time using repeated 
measures mixed models. We estimated relative risk ratios of 
child overweight/obesity and thinness for EPICure2 compared 
with EPICure using multinomial logistic regression models. 
We further adjusted for perinatal and demographic differences 
between eras in the above models. We performed multiple 
imputation17 as a sensitivity analysis to account for missing data 
(online supplemental table S1). Missing data were imputed by 
chained equations using the STATA ‘MI’ procedure. Imputation 
models were based on the missing at random assumption and 
20 imputed datasets were created. Original and imputed results 
were similar (online supplemental table S2), so we only report 
the original results.
RESULTS
Outcomes for births <27 weeks of gestation in EPICure2
Participants and attrition
Of the 482 EPICure2 invitees at 11 years, 220 gave consent to 
participate. Due to difficulties in scheduling, we evaluated 200 
(19%) of the 1031 EPICure2 EP children known to be alive 
at 3 years. Baseline information for the assessed children was 
compared with the non- evaluated sample (table 1). Assessed EP 
children were more likely to be born to mothers of older age 
and to have received breast milk at discharge; there was a higher 
proportion of South Asian children and lower proportions of 
White and Black children among those assessed. The assessed 
sample is representative of the original cohort in terms of gesta-
tional age, birth weight, sex and other birth characteristics. In 
the EP group, mean (SD) age at assessment was 11.8 (0.5) years; 
mean IMD (SD) was 5.2 (2.8); 50% were boys. These character-
istics did not significantly differ from 143 controls.
Growth at 11 years
Growth data were available for 199 EP children (<27 weeks) 
and 143 controls. Mean z- scores for all growth measures apart 
from BMI in EP children were significantly below controls 
(table 2): Δ was −0.42 SD for weight, −0.45 SD for height and 
−1.05 SD for HC. These differences remained significant after 
adjusting for IMD at 11 years. For EP children, rates of over-
weight and obesity were 16.7% (33/198) and 4.0%, respectively, 
not significantly different from for controls (15.5% and 5.6%, 
respectively). In EP children, mean HC z- score decreased by 0.21 
SD for each gestational week (95% CI 0.01 to 0.41; table 2).
Comparison of outcomes for births <26 weeks of gestation in 
EPICure and EPICure2
Comparative characteristics
In EPICure, 309 children survived to 2.5 years among which 
260 were born to mothers resident in England and 176 were 
assessed at 11 years. In EPICure2, 584 children born <26 weeks’ 
gestation survived to 3 years and 112 were assessed at 11 years. 
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milk, to have parenteral and enteral feeding begun earlier and to 
be born to older mothers (table 3); they were less likely to have 
received postnatal systemic steroids; there were more South 
Asian and Black children and fewer White children in EPICure2. 
At the 11- year assessment, children’s chronological ages were 
significantly higher in EPICure2. The two cohorts were evenly 
matched in birth weight, gestational age, sex, multiple birth and 
IMD at 11 years. Differences in perinatal and demographic char-
acteristics were accounted for when comparing growth between 
the two cohorts.
Comparing growth between two cohorts
Growth measure z- scores were available for 111 EPICure2 chil-
dren and 175 EPICure children. At 11 years, using repeated 
measures mixed models Δ between cohorts for weight was 0.72 
SD (0.47 to 0.96), for height 0.55 SD (0.29 to 0.81) and for 
BMI 0.56 SD (0.24 to 0.87). These differences remained signifi-
cant but reduced after adjustment for perinatal and demographic 
differences between eras (table 4). EPICure2 children had signifi-
cantly lower rates of thinness compared with EPICure children 
(14% vs 27%; table 4). In contrast, Δ for HC z- scores was not 
significantly different in both cohorts and remained similar after 
adjusting for differences in maternal age, ethnicity, days to start 
parenteral nutrition and receipt of breast milk, but it became 
significant after further adjusting for differences in days to start 
enteral feeding and postnatal treatment with systemic steroids 
(Δ −0.46 SD (−0.83 to –0.10); table 4). At 11 years, 69% of 
EPICure2 children had HC z- scores of <–1 SD compared with 
64% in EPICure (p=0.407).
Using repeated measures mixed models the estimated post-
natal fall in mean weight z- scores from birth to EDD was similar 
in both cohorts (figure 1). Both cohorts demonstrated catch- up 
in weight after EDD up to 3 years, but this was estimated to be 
greater in EPICure2 than in EPICure (EPICure2: 1.25 SD (1.12, 
1.38) vs EPICure: 0.53 SD (0.37, 0.70); p<0.001). From 2.5–3 
years to 11 years, improved growth was observed in EPICure2 
compared with EPICure (figure 1). In contrast, HC from birth to 
11 years of age was similar in both cohorts: significantly below 
population norms at all ages, a relative decline from birth to 
2.5–3 years, followed by minimal catch- up (figure 1).
Table 3 Representative status of children born <26 weeks of gestation in England from the EPICure cohorts at 11 years and comparative 
characteristics for the two cohorts




survivors by 2.5 years
Children assessed at 
11 years
Whole sample survivors 
by 3 years
Children assessed at 
11 years 2006 vs 1995
n=260 n=176 n=584 n=112 P value
Gestational age         
  <24 weeks % (n/N) 9.2% (24/260) 10.8% (19/176) 11.3% (66/584) 13.4% (15/112) 0.337
  24 weeks % (n/N) 31.9% (83/260) 33.0% (58/176) 30.3% (177/584) 25.0% (28/112)
  25 weeks % (n/N) 58.8% (153/260) 56.3% (99/176) 58.4% (341/584) 61.6% (69/112)
Birth weight (g) Mean (SD) 748.1 (109.9) (n=260) 745.8 (109.1) (n=176) 735.2 (120.3) (n=584) 739.6 (119.0) (n=112) 0.647
Birth weight z scores Mean (SD) −0.2 (0.8) (n=259) −0.1 (0.8) (n=175) −0.2 (0.7) (n=581) −0.2 (0.7) (n=112) 0.391
Male sex % (n/N) 48.8% (127/260) 45.5% (80/176) 47.9% (280/584) 50.0% (56/112) 0.451
Multiple birth % (n/N) 25.8% (67/260) 29.0% (51/176) 22.1% (129/584) 24.1% (27/112) 0.365
Ethnicity         
  White % (n/N) 73.4% (190/259) 78.9% (138/175) 62.9% (363/577) 55.5% (61/110) <0.001
  Asian % (n/N) 7.3% (19/259) 5.7% (10/175) 10.6% (61/577) 19.1% (21/110)
  Black % (n/N) 17.4% (45/259) 14.9% (26/175) 22.0% (127/577) 20.9% (23/110)
  Other % (n/N) 1.9% (5/259) 0.6% (1/175) 4.5% (26/577) 4.5% (5/110)
Maternal age at delivery Mean (SD) 28.5 (5.9) (n=259) 28.8 (5.7) (n=175) 29.4 (6.4) (n=584) 30.8 (5.7) (n=112) 0.006
Breast milk at any time % (n/N) 85.0% (221/260) 86.4% (152/176) 96.1% (560/583) 100.0% (112/112) <0.001
Parenteral nutrition- amino 
acids begun before day 7
% (n/N) 95.6% (238/249) 95.2% (160/168) 99.7% (581/583) 100.0% (111/111) 0.024
Days to amino acids after 
birth
Median (range) 3 (0–32) (n=249) 3 (0–32) (n=168) 2 (0–14) (n=583) 2 (0–14) (n=111) <0.001
Parenteral nutrition- lipids 
begun before day 7
% (n/N) 85.1% (200/235) 86.3% (138/160) 98.3% (568/578) 99.1% (110/111) <0.001
Days to lipids after birth Median (range) 3 (0–33) (n=235) 3 (0–33) (n=160) 2 (0–14) (n=578) 2 (0–8) (n=111) <0.001
Enteral feeding begun 
before day 7
% (n/N) 47.6% (121/254) 49.1% (84/171) 82.2% (480/584) 86.6% (97/112) <0.001
Days to enteral feeding 
after birth
Median (range) 8 (2–43) (n=254) 8 (2–41) (n=171) 3 (0–31) (n=584) 3 (0–24) (n=112) <0.001
Antenatal systemic steroids % (n/N) 79.9% (207/259) 82.3% (144/175) 87.9% (509/579) 88.4% (99/112) 0.161
Postnatal systemic steroids % (n/N) 71.4% (185/259) 71.4% (125/175) 20.4% (119/584) 24.1% (27/112) <0.001
IMD at birth Mean (SD) – – 4.2 (2.9) (n=581) 4.3 (2.7) (n=111) –
IMD at 11 years Mean (SD) – 5.1 (2.8) (n=174) – 4.9 (2.8) (n=111) 0.604
Age assessed at infancy Mean (SD) 2.5 (0.1) (n=235) 2.5 (0.1) (n=171) 2.9 (0.4) (n=325) 2.9 (0.3) (n=88) <0.001
Age assessed at 11 years Mean (SD) – 10.9 (0.4) (n=176) – 11.9 (0.5) (n=112) <0.001
IMD, Index of Multiple Deprivation.
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DISCUSSION
We have reported growth outcomes at 11 years of age for EP chil-
dren and term- born controls in EPICure2 and compared growth 
outcomes from birth to age 11 years for children born <26 
weeks’ gestation with EPICure. In EPICure2 at 11 years, mean 
growth in weight and length were comparable to the UK 1990 
growth standards, but EP children were significantly shorter 
and lighter than controls at 11 years. Rates of overweight and 
obesity were similar in two groups. Compared with EPICure, 
improvements were observed in weight, height and BMI during 
infancy and middle childhood in EPICure2 and reassuringly the 
rate of thinness was lower in EPICure2 than in EPICure. Greater 
catch- up in weight from EDD to 2.5–3 years was observed in 
EPICure2 compared with EPICure. In contrast, head growth was 
poor during childhood in both studies.
Our data show that weight, height and BMI during infancy 
and middle childhood have improved for babies born <26 weeks 
of gestation in 2006 compared with births in 1995, contrasting 
Table 4 A comparison of growth measures between 1995 and 2006 for children born <26 weeks of gestation in England
EPICure 1995 EPICure2 2006 2006 vs 1995 2006 vs 1995
Mean (95% CI) Mean (95% CI)
Unadjusted difference in 
means (95% CI)*
Adjusted difference in 
means (95% CI)*
Birth     
Weight z- score −0.16 (−0.25 to −0.07) (n=265) −0.25 (−0.31 to −0.19) (n=590) −0.09 (−0.24 to 0.07) −0.26 (−0.45 to –0.07)
Head circumference 
z- score
−0.23 (−0.42 to −0.05) (n=171) −0.40 (−0.51 to −0.28) (n=291) −0.17 (−0.43 to 0.04) −0.44 (−0.74 to –0.13)
EDD     
Weight z- score −1.73 (−1.86 to −1.60) (n=251) −1.95 (−2.05 to −1.85) (n=581) −0.23 (−0.39 to –0.07) −0.40 (−0.58 to –0.21)
Head circumference 
z- score
−0.98 (−1.17 to −0.78) (n=244) −1.29 (−1.43 to −1.16) (n=552) −0.33 (−0.54 to –0.12) −0.60 (−0.86 to –0.34)
2.5–3 years†     
Height z- score −0.65 (−0.81 to −0.49) (n=216) −0.44 (−0.60 to −0.27) (n=301) 0.21 (−0.00 to 0.43) 0.14 (−0.13 to 0.42)
Weight z- score −1.20 (−1.37 to −1.03) (n=225) −0.69 (−0.84 to −0.55) (n=316) 0.49 (0.31 to 0.67) 0.30 (0.09 to 0.51)
BMI z- score −1.07 (−1.26 to −0.88) (n=211) −0.48 (−0.63 to −0.33) (n=294) 0.59 (0.36 to 0.83) 0.58 (0.28 to 0.88)
Head circumference 
z- score
−1.65 (−1.84 to −1.46) (n=231) −1.73 (−1.89 to −1.58) (n=316) −0.13 (−0.37 to 0.11) −0.38 (−0.66 to –0.10)
11 years     
Height z- score −0.51 (−0.66 to −0.36) (n=175) 0.10 (−0.13 to 0.33) (n=111) 0.55 (0.29 to 0.81) 0.43 (0.11 to 0.74)
Weight z- score −0.48 (−0.66 to −0.30) (n=174) 0.24 (−0.01 to 0.48) (n=112) 0.72 (0.47 to 0.96) 0.51 (0.24 to 0.78)
BMI z- score −0.34 (−0.53 to −0.14) (n=174) 0.23 (−0.02 to 0.49) (n=111) 0.56 (0.24 to 0.87) 0.50 (0.13 to 0.87)
Head circumference 
z- score
−1.35 (−1.54 to −1.16) (n=174) −1.57 (−1.83 to −1.31) (n=106) −0.23 (−0.56 to 0.09) −0.46 (−0.83 to –0.10)
% (n/N) % (n/N)
Overweight/obesity vs normal 
weight
Unadjusted RRR (95% CI)‡
Thinness vs normal weight
Unadjusted RRR (95% CI)‡
Overweight/obesity vs 
normal weight
Adjusted RRR (95% CI)*
Thinness vs normal 
weight
Adjusted RRR (95% CI)*





1.48 (0.71 to 3.09) 0.54 (0.37 to 0.79) 2.85 (1.14 to 7.12) 0.65 (0.39 to 1.10)

















1.31 (0.85 to 2.01) 0.48 (0.29 to 0.79) 2.10 (0.86 to 5.12) 0.59 (0.25 to 1.35)












Bold fonts indicate significant differences between the two cohorts.
*Differences in mean z- scores for growth measures between the two cohorts at comparable ages were estimated using repeated measures mixed models. We adjusted for 
differences in perinatal and demographic characteristics, including maternal age at delivery, ethnicity (white, black, South Asian or other), days to start amino acids, days to start 
lipids, days to start enteral feeding, breast milk at any time (yes vs no), any postnatal systemic steroids (yes vs no).
†Growth measures corrected for prematurity at 2.5–3 years.
‡RRRs of child overweight/obesity and thinness for EPICure2 2006 compared with EPICure 1995 were estimated using multinomial logistic regression models.
EDD, expected date of delivery; RRR, relative risk ratio.
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with the Victorian Cohort which showed no improvement in 
growth across three eras: 1991–1992, 1997 and 2005.18 In our 
study, improvements were partly explained by known perinatal 
and demographic differences between eras. This might also 
partly reflect secular trends in human physical growth,19 20 as 
this was also shown in controls (online supplemental table S3). 
Secular changes are directly linked to improved access to health 
and nutrition and also correlated with education, income and 
social status and infection.20 Moreover, secular gains in weight 
and BMI may reflect reductions in physical activity associated 
with an increasingly sedentary lifestyle.21
Greater catch- up in weight from EDD to 2.5–3 years occurred 
in EPICure2 than in EPICure. This may be of concern, because 
evidence from both term and preterm populations shows an 
association of rapid catch- up growth in infancy and early child-
hood with increased risk for cardiovascular disease and type 2 
diabetes in adulthood.22–27 In particular, we have also shown that 
EP young adults with metabolic syndrome at 19 years tended to 
have greater catch- up in weight from EDD to 2.5 years compared 
with those without metabolic syndrome.28
Our comparison of the two cohorts shows that, despite 
improvements in perinatal care, there was no improvement in 
head growth: after full adjustment, EPICure2 children had heads 
0.46 SD smaller than the earlier cohort. Brain development 
begins in the second trimester of pregnancy and continues into 
adult life, and multiple complex events critical for brain devel-
opment occur between 24 and 40 weeks’ gestation.29 30 Thus, 
lower gestation at birth is associated with smaller brain volume 
at birth and in the early postnatal period31 32 and positive asso-
ciations of postnatal head growth with neurocognitive outcomes 
have been demonstrated at ages ranging from infancy to adult-
hood in preterm populations.33 34 The lack of improvement in 
head growth may reflect the lack of change in neurodevelop-
mental outcomes between the two cohorts.12 Interestingly, we 
also observed an unexplained decrease in head size in controls 
(−0.32 SD; online supplemental table S3).
The strengths of this paper include comparing identical growth 
measures across two cohorts using common standards, applying 
multiple imputation to account for missing data and recruiting 
a contemporary comparison group for each. The major limita-
tion in EPICure2 is the small number of participants seen at 11 
years representing 41.5% (200/482) of the chosen sample; thus, 
the proportion lost to follow- up increased over time, as shown 
in EPICure.4 However, drop- out analysis showed that children 
assessed at 11 years were representative of the original cohort in 
baseline characteristics, and our findings were strengthened by 
using multiple imputation. Further, controls were recruited from 
mainstream schools and might be relatively more healthy than 
the general population. Data from the National Child Measure-
ment Programme for England show that the prevalence of obesity 
for children aged 10–11 was 20% in 2017/2018 in England. 
Thus, group differences in BMI and rates of overweight/obesity 
may have been underestimated in this study. It is also possible 
that group difference in height may have been overestimated. 
Additionally, although the two cohorts were comparable in birth 
characteristics and IMD at 11 years, EPICure2 EP children were 
on average 1 year older than those in EPICure. However, we 
used z- scores based on UK norms which were adjusted for age 
and sex. Last, significant differences were found in other peri-
natal and demographic characteristics between cohorts, but they 
were adjusted for in the models and did not fully explain differ-
ences in somatic growth over time.
Despite advancing perinatal care and survival since 1995, 
head growth has not improved for children born <26 weeks’ 
gestation in 2006. No improvement in brain volume develop-
ment may indicate similar neurocognitive development in the 
two cohorts. Early head growth failure could be improved by 
increasing breast milk feeding35 or parenteral nutrition protein 
Figure 1 Observed means and 95% CIs in z- scores for growth parameters at different ages in 1995 (EPICure) and 2006 (EPICure2).
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and calorie intake in early life.36 37 In contrast, we have shown 
improvements in somatic growth during infancy and middle 
childhood among EPICure2 children, who have greater weight 
catch- up in infancy, that is maintained. By age 11, EPICure2 EP 
children do remain shorter and lighter than term- born controls, 
but rates of overweight and obesity were similar and growth 
attainment in weight and height was not different from the popu-
lation norms used. Growth in childhood remains an important 
issue in preterm populations and new strategies to improve head 
growth in particular across childhood are urgently needed. It is 
important to alert parents/carers and primary healthcare profes-
sionals of the increasing evidence of metabolic risk from being 
overweight/obese for EP children.
Twitter Yanyan Ni @Yanyan_Ni
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